Cargando…

Independent calculation of dose from a helical TomoTherapy unit

A new calculation algorithm has been developed for independently verifying doses calculated by the TomoTherapy(®) Hi·Art(®) treatment planning system (TPS). The algorithm is designed to confi rm the dose to a point in a high dose, low dose‐gradient region. Patient data used by the algorithm include...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibbons, John P., Smith, Koren, Cheek, Dennis, Rosen, Isaac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720509/
https://www.ncbi.nlm.nih.gov/pubmed/19223830
http://dx.doi.org/10.1120/jacmp.v10i1.2772
Descripción
Sumario:A new calculation algorithm has been developed for independently verifying doses calculated by the TomoTherapy(®) Hi·Art(®) treatment planning system (TPS). The algorithm is designed to confi rm the dose to a point in a high dose, low dose‐gradient region. Patient data used by the algorithm include the radiological depth to the point for each projection angle and the treatment sinogram file controlling the leaf opening time for each projection. The algorithm uses common dosimetric functions [tissue phantom ratio (TPR) and output factor ([Formula: see text])] for the central axis combined with lateral and longitudinal beam profile data to quantify the off‐axis dose dependence. Machine data for the dosimetric functions were measured on the Hi·Art machine and simulated using the TPS. Point dose calculations were made for several test phantoms and for 97 patient treatment plans using the simulated machine data. Comparisons with TPS‐predicted point doses for the phantom treatment plans demonstrated agreement within 2% for both on‐axis and off‐axis planning target volumes (PTVs). Comparisons with TPS‐predicted point doses for the patient treatment plans also showed good agreement. For calculations at sites other than lung and superficial PTVs, agreement between the calculations was within 2% for 94% of the patient calculations (64 of 68). Calculations within lung and superficial PTVs overestimated the dose by an average of 3.1% ([Formula: see text]) and 3.2% ([Formula: see text]), respectively. Systematic errors within lung are probably due to the weakness of the algorithm in correcting for missing tissue and/or tissue density heterogeneities. Errors encountered within superficial PTVs probably result from the algorithm overestimating the scatter dose within the patient. Our results demonstrate that for the majority of cases, the algorithm could be used without further refinement to independently verify patient treatment plans. PACS number(s): 87.53.Bn, 87.53.Dq, 87.53.Xd